SCICALI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 2.633
EU - Europa 1.495
AS - Asia 1.152
SA - Sud America 313
AF - Africa 288
Totale 5.881
Nazione #
US - Stati Uniti d'America 2.579
IT - Italia 920
SG - Singapore 577
CN - Cina 291
BR - Brasile 288
IE - Irlanda 238
CI - Costa d'Avorio 181
IN - India 99
SN - Senegal 76
DE - Germania 61
VN - Vietnam 59
UA - Ucraina 52
CA - Canada 45
RU - Federazione Russa 45
KR - Corea 40
SE - Svezia 35
FI - Finlandia 33
GB - Regno Unito 33
NL - Olanda 19
TR - Turchia 18
FR - Francia 16
HK - Hong Kong 14
NG - Nigeria 13
PL - Polonia 10
UZ - Uzbekistan 10
MA - Marocco 8
AR - Argentina 7
PK - Pakistan 7
IQ - Iraq 6
AT - Austria 5
BD - Bangladesh 5
CH - Svizzera 5
ES - Italia 5
BG - Bulgaria 4
CL - Cile 4
MX - Messico 4
VE - Venezuela 4
BE - Belgio 3
CO - Colombia 3
JP - Giappone 3
KE - Kenya 3
TH - Thailandia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GR - Grecia 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HN - Honduras 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TG - Togo 1
TN - Tunisia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.881
Città #
Santa Clara 698
Chandler 434
Singapore 372
Chicago 273
Dublin 235
Abidjan 181
Catania 170
Civitanova Marche 152
Boardman 118
Ashburn 95
Hefei 84
Rome 83
Kochi 81
Dakar 76
Cambridge 66
Lawrence 60
Andover 58
Jacksonville 56
Dong Ket 51
Wilmington 42
Seoul 40
Des Moines 34
Beijing 30
Nanjing 28
Milan 26
Toronto 26
Bremen 24
Los Angeles 23
Palermo 21
The Dalles 21
Carrara 19
Padova 19
Lappeenranta 16
São Paulo 15
Belo Horizonte 14
Houston 14
Messina 14
Munich 14
Saint Petersburg 14
Columbus 13
Abuja 12
Hong Kong 12
Menlo Park 12
San Francisco 12
Seattle 12
Shenyang 11
Turku 11
Council Bluffs 10
Gravina di Catania 10
Hebei 10
New York 9
San Mateo 9
Washington 9
Istanbul 8
Ottawa 8
Reggio Emilia 8
Bari 7
Brasília 7
Hanoi 7
Pollenza 7
Rio de Janeiro 7
Warsaw 7
Brooklyn 6
Enna 6
Helsinki 6
Leawood 6
London 6
Naples 6
Aci Sant'Antonio 5
Amsterdam 5
Civitavecchia 5
Curitiba 5
Guangzhou 5
Jiaxing 5
Nanchang 5
Ragusa 5
Salvador 5
Sankt Augustin 5
Shanghai 5
Tashkent 5
Tianjin 5
Woodbridge 5
Belpasso 4
Boydton 4
Cagliari 4
Dallas 4
Genoa 4
Giarre 4
Misilmeri 4
Montreal 4
Mumbai 4
Redmond 4
Santiago 4
Vallefiorita 4
Ankara 3
Baghdad 3
Barcelona 3
Betim 3
Boston 3
Camaçari 3
Totale 4.187
Nome #
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 155
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 107
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 105
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 100
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 100
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 98
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 96
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 94
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 93
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 92
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 89
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 89
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 86
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 82
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 81
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 80
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 79
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 79
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 79
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 79
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 77
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 77
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 77
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 76
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 76
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 75
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 75
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 73
Clinical and molecular biomarkers for diagnosis and staging of nafld 71
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 71
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 69
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 69
HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients 69
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 68
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 68
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 66
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 66
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 65
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 65
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 63
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 61
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 60
Corticosteroid replacement therapy in hepatoadrenal syndrome: case report with a review of the literature. 59
Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency 59
Left ventricular geometry and periodontitis in patients with the metabolic syndrome 59
Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile 59
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 59
Impact of high neutrophil-to-lymphocyte ratio on the cardiovascular benefit of PCSK9 inhibitors in familial hypercholesterolemia subjects with atherosclerotic cardiovascular disease: Real-world data from two lipid units 59
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 58
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 58
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease 57
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 57
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 57
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 56
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients with Stable Cirrhosis. 55
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy 55
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 54
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN) 53
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 53
Increased Platelet Reactivity and Proinflammatory Profile Are Associated with Intima-Media Thickness and Arterial Stiffness in Prediabetes 53
L'emoglobina glicosilata, meglio della curva da carico, permette l'identificazione di soggetti con prediabete ed elevato rischio cardiovascolare 51
Studio dell'effetto incretinivo e della funzione beta cellulare in soggetti con prediabete e diabete di neo diagnosi 51
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 50
Proprotein convertase subtilisin kexin type 9 inhibitors reduce platelet activation modulating ox-LDL pathways 50
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 49
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 49
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 48
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 48
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 48
Identification of a New RNA and Protein Integrated Biomarker Panel Associated with Kidney Function Impairment in DKD: Translational Implications 47
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? 47
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study 47
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 47
Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease 46
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study 44
Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice 44
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 44
Implications of GLP-1 Receptor Agonist on Thyroid Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels 43
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues 42
Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units 42
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk 41
Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction—An Updated Review of the Literature 40
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies 39
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 38
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies 37
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia 37
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 37
Impatto del profilo lipidico sulla malattia aterosclerotica in due differenti coorti di pazienti ad alto rischio cardiovascolare 36
Is the relationship between erythropoiesis and renal function one of the secrets of extreme longevity? 35
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 35
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 35
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 35
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 33
Advancements in risk stratification and management strategies in primary cardiovascular prevention 33
Associations between Host Genetic Variants and Subgingival Microbiota in Patients with the Metabolic Syndrome 32
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 31
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 30
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 22
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 22
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 20
Totale 6.025
Categoria #
all - tutte 25.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 7 16 12 5 47 15 19 3 14 37 31 62
2021/2022534 37 57 1 21 90 38 70 41 27 7 21 124
2022/20231.115 69 95 33 137 105 170 5 192 214 14 42 39
2023/2024798 37 118 50 27 45 165 52 89 10 27 104 74
2024/20252.943 70 400 138 261 554 390 134 77 145 226 337 211
2025/2026151 151 0 0 0 0 0 0 0 0 0 0 0
Totale 6.101